Oncternal Therapeutics Inc

General ticker "ONCT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.2M

Oncternal Therapeutics Inc does not follow the US Stock Market performance with the rate: -38.7%.

Estimated limits based on current volatility of 1.7%: low 0.53$, high 0.55$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.65$, 16.30$]
  • 2024-12-30 to 2025-12-30 estimated range: [5.54$, 15.18$]

Financial Metrics affecting the ONCT estimates:

  • Negative: Non-GAAP EPS, $ of -13.51 <= 0.10
  • Negative: Operating profit margin, % of -98.15 <= 1.03
  • Negative: Operating cash flow per share per price, % of -56.80 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term ONCT quotes

Long-term ONCT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $4.32MM $1.49MM $0.79MM
Operating Expenses $35.68MM $46.44MM $42.50MM
Operating Income $-31.37MM $-44.95MM $-41.71MM
Non-Operating Income $0.37MM $0.78MM $2.23MM
R&D Expense $24.09MM $32.98MM $29.75MM
Income(Loss) $-31.00MM $-44.17MM $-39.48MM
Profit(Loss) $-31.00MM $-44.17MM $-39.48MM
Stockholders Equity $88.12MM $60.97MM $30.05MM
Inventory $0.94MM $0.10MM $0.00MM
Assets $93.58MM $68.65MM $36.73MM
Operating Cash Flow $-26.59MM $-36.70MM $-32.16MM
Investing Cash Flow $0.00MM $-26.50MM $0.65MM
Financing Cash Flow $0.62MM $9.58MM $1.07MM
Earnings Per Share* $-12.69 $-16.50 $-13.43

* EPS are Split Adjusted, recent splits may be reflected with a delay.